Different genetic features associated with colon and rectal carcinogenesis

Milo Frattini, Debora Balestra, Simona Suardi, Maria Oggionni, Paola Alberici, Paolo Radice, Aurora Costa, Maria Grazia Daidone, Ermanno Leo, Silvana Pilotti, Lucio Bertario, Marco A. Pierotti

Research output: Contribution to journalArticle

162 Citations (Scopus)

Abstract

Purpose: The issue of whether colon and rectal cancer should be considered as a single entity or two distinct entities is still debated, and there is a need to improve studies addressing the heterogeneity of the pathogenetic pathway leading to sporadic colorectal cancers (SCRCs) as well as to identify biological and/or molecular differences between colon and rectal cancers. Experimental Design: Specimens of SCRCs were analyzed for somatic mutations in APC, K-ras, and TP53 genes and loss-of-heterozygosity of chromosome 18. Results: Eleven SCRCs showed microsatellite instability. APC mutation frequency was significantly lower in microsatellite instability (MIN+) than in MIN- SCRCS. All MIN- SCRCs showed β-catenin overexpression. A combined analysis of the biomarkers revealed two pathways mainly represented by MIN- SCRCs and differently followed on the basis of tumor location, APC-K-ras-TP53-Ch18q and APC-TP53-Ch18q. Conclusions: The APC-β-catenin pathway is inactivated in MIN- SCRCs and represents the first hit of SCRC development. Two preferential pathways followed by SCRCs occur, one K-ras dependent, in agreement with the Fearon and Vogelstein model, and the other K-ras independent. Significant differences between colon and rectal tumors occur in our series of MIN- SCRCs. The different pathways observed and their distribution can be summarized as follows: (a) K-ras mutations were more commonly detected in colon than in rectum; (b) the number of mutations detected was significantly higher in colon than in rectal tumors; and (c) a mutational pattern restricted to the APC gene was more common in rectal than in colon tumors. This molecular characterization can be translated into a clinical setting to improve diagnosis and to direct a rationale pharmacological treatment.

Original languageEnglish
Pages (from-to)4015-4021
Number of pages7
JournalClinical Cancer Research
Volume10
Issue number12 I
DOIs
Publication statusPublished - Jul 15 2004

Fingerprint

Colorectal Neoplasms
Colon
Carcinogenesis
Rectal Neoplasms
Catenins
Microsatellite Instability
Colonic Neoplasms
Mutation
APC Genes
Chromosomes, Human, Pair 18
ras Genes
Loss of Heterozygosity
p53 Genes
Mutation Rate
Rectum
Neoplasms
Research Design
Biomarkers
Pharmacology

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Frattini, M., Balestra, D., Suardi, S., Oggionni, M., Alberici, P., Radice, P., ... Pierotti, M. A. (2004). Different genetic features associated with colon and rectal carcinogenesis. Clinical Cancer Research, 10(12 I), 4015-4021. https://doi.org/10.1158/1078-0432.CCR-04-0031

Different genetic features associated with colon and rectal carcinogenesis. / Frattini, Milo; Balestra, Debora; Suardi, Simona; Oggionni, Maria; Alberici, Paola; Radice, Paolo; Costa, Aurora; Daidone, Maria Grazia; Leo, Ermanno; Pilotti, Silvana; Bertario, Lucio; Pierotti, Marco A.

In: Clinical Cancer Research, Vol. 10, No. 12 I, 15.07.2004, p. 4015-4021.

Research output: Contribution to journalArticle

Frattini, M, Balestra, D, Suardi, S, Oggionni, M, Alberici, P, Radice, P, Costa, A, Daidone, MG, Leo, E, Pilotti, S, Bertario, L & Pierotti, MA 2004, 'Different genetic features associated with colon and rectal carcinogenesis', Clinical Cancer Research, vol. 10, no. 12 I, pp. 4015-4021. https://doi.org/10.1158/1078-0432.CCR-04-0031
Frattini, Milo ; Balestra, Debora ; Suardi, Simona ; Oggionni, Maria ; Alberici, Paola ; Radice, Paolo ; Costa, Aurora ; Daidone, Maria Grazia ; Leo, Ermanno ; Pilotti, Silvana ; Bertario, Lucio ; Pierotti, Marco A. / Different genetic features associated with colon and rectal carcinogenesis. In: Clinical Cancer Research. 2004 ; Vol. 10, No. 12 I. pp. 4015-4021.
@article{bcb6a0adf54549a59c5284d693032a1e,
title = "Different genetic features associated with colon and rectal carcinogenesis",
abstract = "Purpose: The issue of whether colon and rectal cancer should be considered as a single entity or two distinct entities is still debated, and there is a need to improve studies addressing the heterogeneity of the pathogenetic pathway leading to sporadic colorectal cancers (SCRCs) as well as to identify biological and/or molecular differences between colon and rectal cancers. Experimental Design: Specimens of SCRCs were analyzed for somatic mutations in APC, K-ras, and TP53 genes and loss-of-heterozygosity of chromosome 18. Results: Eleven SCRCs showed microsatellite instability. APC mutation frequency was significantly lower in microsatellite instability (MIN+) than in MIN- SCRCS. All MIN- SCRCs showed β-catenin overexpression. A combined analysis of the biomarkers revealed two pathways mainly represented by MIN- SCRCs and differently followed on the basis of tumor location, APC-K-ras-TP53-Ch18q and APC-TP53-Ch18q. Conclusions: The APC-β-catenin pathway is inactivated in MIN- SCRCs and represents the first hit of SCRC development. Two preferential pathways followed by SCRCs occur, one K-ras dependent, in agreement with the Fearon and Vogelstein model, and the other K-ras independent. Significant differences between colon and rectal tumors occur in our series of MIN- SCRCs. The different pathways observed and their distribution can be summarized as follows: (a) K-ras mutations were more commonly detected in colon than in rectum; (b) the number of mutations detected was significantly higher in colon than in rectal tumors; and (c) a mutational pattern restricted to the APC gene was more common in rectal than in colon tumors. This molecular characterization can be translated into a clinical setting to improve diagnosis and to direct a rationale pharmacological treatment.",
author = "Milo Frattini and Debora Balestra and Simona Suardi and Maria Oggionni and Paola Alberici and Paolo Radice and Aurora Costa and Daidone, {Maria Grazia} and Ermanno Leo and Silvana Pilotti and Lucio Bertario and Pierotti, {Marco A.}",
year = "2004",
month = "7",
day = "15",
doi = "10.1158/1078-0432.CCR-04-0031",
language = "English",
volume = "10",
pages = "4015--4021",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "12 I",

}

TY - JOUR

T1 - Different genetic features associated with colon and rectal carcinogenesis

AU - Frattini, Milo

AU - Balestra, Debora

AU - Suardi, Simona

AU - Oggionni, Maria

AU - Alberici, Paola

AU - Radice, Paolo

AU - Costa, Aurora

AU - Daidone, Maria Grazia

AU - Leo, Ermanno

AU - Pilotti, Silvana

AU - Bertario, Lucio

AU - Pierotti, Marco A.

PY - 2004/7/15

Y1 - 2004/7/15

N2 - Purpose: The issue of whether colon and rectal cancer should be considered as a single entity or two distinct entities is still debated, and there is a need to improve studies addressing the heterogeneity of the pathogenetic pathway leading to sporadic colorectal cancers (SCRCs) as well as to identify biological and/or molecular differences between colon and rectal cancers. Experimental Design: Specimens of SCRCs were analyzed for somatic mutations in APC, K-ras, and TP53 genes and loss-of-heterozygosity of chromosome 18. Results: Eleven SCRCs showed microsatellite instability. APC mutation frequency was significantly lower in microsatellite instability (MIN+) than in MIN- SCRCS. All MIN- SCRCs showed β-catenin overexpression. A combined analysis of the biomarkers revealed two pathways mainly represented by MIN- SCRCs and differently followed on the basis of tumor location, APC-K-ras-TP53-Ch18q and APC-TP53-Ch18q. Conclusions: The APC-β-catenin pathway is inactivated in MIN- SCRCs and represents the first hit of SCRC development. Two preferential pathways followed by SCRCs occur, one K-ras dependent, in agreement with the Fearon and Vogelstein model, and the other K-ras independent. Significant differences between colon and rectal tumors occur in our series of MIN- SCRCs. The different pathways observed and their distribution can be summarized as follows: (a) K-ras mutations were more commonly detected in colon than in rectum; (b) the number of mutations detected was significantly higher in colon than in rectal tumors; and (c) a mutational pattern restricted to the APC gene was more common in rectal than in colon tumors. This molecular characterization can be translated into a clinical setting to improve diagnosis and to direct a rationale pharmacological treatment.

AB - Purpose: The issue of whether colon and rectal cancer should be considered as a single entity or two distinct entities is still debated, and there is a need to improve studies addressing the heterogeneity of the pathogenetic pathway leading to sporadic colorectal cancers (SCRCs) as well as to identify biological and/or molecular differences between colon and rectal cancers. Experimental Design: Specimens of SCRCs were analyzed for somatic mutations in APC, K-ras, and TP53 genes and loss-of-heterozygosity of chromosome 18. Results: Eleven SCRCs showed microsatellite instability. APC mutation frequency was significantly lower in microsatellite instability (MIN+) than in MIN- SCRCS. All MIN- SCRCs showed β-catenin overexpression. A combined analysis of the biomarkers revealed two pathways mainly represented by MIN- SCRCs and differently followed on the basis of tumor location, APC-K-ras-TP53-Ch18q and APC-TP53-Ch18q. Conclusions: The APC-β-catenin pathway is inactivated in MIN- SCRCs and represents the first hit of SCRC development. Two preferential pathways followed by SCRCs occur, one K-ras dependent, in agreement with the Fearon and Vogelstein model, and the other K-ras independent. Significant differences between colon and rectal tumors occur in our series of MIN- SCRCs. The different pathways observed and their distribution can be summarized as follows: (a) K-ras mutations were more commonly detected in colon than in rectum; (b) the number of mutations detected was significantly higher in colon than in rectal tumors; and (c) a mutational pattern restricted to the APC gene was more common in rectal than in colon tumors. This molecular characterization can be translated into a clinical setting to improve diagnosis and to direct a rationale pharmacological treatment.

UR - http://www.scopus.com/inward/record.url?scp=3042533718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042533718&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-04-0031

DO - 10.1158/1078-0432.CCR-04-0031

M3 - Article

VL - 10

SP - 4015

EP - 4021

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 12 I

ER -